u/ferran_mensah

What is the actual shortage list status right now?

the milestone change matters as much as the scale

the 15mg is the top of the pen, not the required dose

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Strongly agree. Tirz is better than sema is not a claim without a comparator dose.

Came off after 49 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

pregnancy and trying-to-conceive get clinician pointer, not community advice

The satiety on amylin analogs is described as physically different.

Disagree on that part. 98.1% and 99.3% on the same vial is normal.

The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does co-agonism.

CagriSema ratios in trials are fixed, do not extrapolate self-mixing

SURMOUNT data is messier than STEP data but the weight loss is there

Crossposting this to c/labresults because the people who need it are not reading this community.

Yeah, 503A and 503B are different regulatory animals.

The confident tone is doing a lot of work that the evidence is not.

regulatory claims need a citation to the actual rule, not interpretation

Adding to this: API source is doing more work than the comment implies.

API transparency is the question that separates good compounders from sketchy ones

You have restated the marketing copy. What is the actual substance here.

SURMOUNT data is messier than STEP data but the weight loss is there

no pharmacy referral codes, naming is fine, recruiting is not

Slight fix: the number was 97.2, not 97.4. Decimal point, but a fairly consequential one.